# Severe Intraocular Inflammation Following Intravitreal Faricimab

*PRI Rank #19 · Topics and Trends in Most Cited Retinal Diseases and Treatments Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/retinal-diseases-and-treatments/2026/rank-19*

| Field | Value |
| --- | --- |
| Rank | #19 |
| 18m citations | 43 |
| Journal | JAMA Ophthalmology |
| Year | 2024 |
| DOI | 10.1001/jamaophthalmol.2024.0530 |
| Corresponding authors | Neil M. Bressler |
| Institution | Johns Hopkins University, United States |

**Ranking page:** [Topics and Trends in Most Cited Retinal Diseases and Treatments Papers, Class of 2026](https://pri.pepkio.com/top-papers/retinal-diseases-and-treatments/2026)

**Paper link:** [10.1001/jamaophthalmol.2024.0530](https://doi.org/10.1001/jamaophthalmol.2024.0530)

## Topics

Faricimab · Intraocular inflammation · Sterile endophthalmitis · Neovascular age-related macular degeneration · brolucizumab · Pegcetacoplan · Aflibercept · bevacizumab · vitreous tap · intravitreal ceftazidime · intravitreal vancomycin · vitrectomy · Staphylococcus epidermidis contaminant · visual acuity outcomes · Intraocular inflammation · Intraocular inflammation · Case series · drug storage or handling problem · post-marketing surveillance · lot number cluster

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Retinal Diseases and Treatments Papers, Class of 2026. https://pri.pepkio.com/top-papers/retinal-diseases-and-treatments/2026. Accessed 2026-07-14.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```